Shionogi & Co., Ltd.

Shionogi & Co., Ltd.verified

SGIOF

Price:

$12.41

Market Cap:

$1.63T

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Xofluza, an influenza virus drug; and Tivicay for HIV treatment. It also develops Symproic for opioid-induced constipation treatment; S-120083 for Inflammatory pain; S-010887 for Neuropathic pain; S-117957 for Insomnia; sivopixant for Neuropathic pain, Sleep Apnea Syndrome, and Refractory/unexplainedchronic cough; S-637880 for Neuropathic Low Back Pain; Zuranolone for Depression; SDT-001 for attention-deficit/hyperactivity disorder patients; BPN1...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2018-02-28

Stock Exchange

PNK

Ticker

SGIOF

The Enterprise Value as of November 2024 (TTM) for Shionogi & Co., Ltd. (SGIOF) is 1.36T

According to Shionogi & Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.36T. This represents a change of 280.87% compared to the average of 357.20B of the last 4 quarters.

Shionogi & Co., Ltd. (SGIOF) Historical Enterprise Value (quarterly & annually)

How has SGIOF Enterprise Value performed in the past?

The mean historical Enterprise Value of Shionogi & Co., Ltd. over the last ten years is 429.64B. The current 1.36T Enterprise Value has changed 31.57% with respect to the historical average. Over the past ten years (40 quarters), SGIOF's Enterprise Value was at its highest in in the December 2021 quarter at 629.88B. The Enterprise Value was at its lowest in in the September 2014 quarter at 150.00B.

Quarterly (TTM)
Annual

Average

429.64B

Median

443.98B

Minimum

304.35B

Maximum

546.56B

Shionogi & Co., Ltd. (SGIOF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Shionogi & Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 100.63%

Maximum Annual Enterprise Value = 546.56B

Minimum Annual Increase = -38.46%

Minimum Annual Enterprise Value = 304.35B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024380.98B25.18%
2023304.35B-38.46%
2022494.57B42.10%
2021348.05B2.26%
2020340.35B-33.90%
2019514.92B11.40%
2018462.21B-15.43%
2017546.56B14.19%
2016478.63B12.42%
2015425.74B100.63%

Shionogi & Co., Ltd. (SGIOF) Average Enterprise Value

How has SGIOF Enterprise Value performed in the past?

The current Enterprise Value of Shionogi & Co., Ltd. (SGIOF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

393.30B

5-year avg

373.66B

10-year avg

429.64B

Shionogi & Co., Ltd. (SGIOF) Enterprise Value vs. Peers

How is SGIOF’s Enterprise Value compared to its peers?

Shionogi & Co., Ltd.’s Enterprise Value is greater than Taisho Pharmaceutical Holdings Co., Ltd. (446.34B), greater than Vivesto AB (151.49M), greater than Acorda Therapeutics, Inc. (187.38M), greater than Pacira BioSciences, Inc. (1.21B), less than Shionogi & Co., Ltd. (1.50T), greater than Sunshine Biopharma, Inc. (-6930906.00), greater than Alimera Sciences, Inc. (362.58M), greater than China SXT Pharmaceuticals, Inc. (-8091895.00), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than Cresco Labs Inc. (1.02B), greater than Curaleaf Holdings, Inc. (2.23B), greater than Trulieve Cannabis Corp. (1.70B), greater than Journey Medical Corporation (109.54M), greater than Aurora Cannabis Inc. (324.31M), greater than Ironwood Pharmaceuticals, Inc. (677.16M), greater than Assertio Holdings, Inc. (91.56M), greater than Neurocrine Biosciences, Inc. (12.62B), greater than Deciphera Pharmaceuticals, Inc. (2.15B), greater than Esperion Therapeutics, Inc. (620.77M),

Build a custom stock screener for Shionogi & Co., Ltd. (SGIOF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shionogi & Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shionogi & Co., Ltd. (SGIOF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shionogi & Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Shionogi & Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Shionogi & Co., Ltd. (SGIOF)?

What is the 3-year average Enterprise Value for Shionogi & Co., Ltd. (SGIOF)?

What is the 5-year average Enterprise Value for Shionogi & Co., Ltd. (SGIOF)?

How does the current Enterprise Value for Shionogi & Co., Ltd. (SGIOF) compare to its historical average?